BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 9202073)

  • 21. IFN-gamma increases cathepsin H mRNA levels in mouse macrophages.
    Lafuse WP; Brown D; Castle L; Zwilling BS
    J Leukoc Biol; 1995 Apr; 57(4):663-9. PubMed ID: 7722423
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HLA-DM can partially replace the invariant chain for HLA-DR transport and surface expression in transfected endocrine epithelial cells.
    Serradell L; Muntasell A; Catálfamo M; Martí M; Costa M; de Préval C; Jaraquemada D
    Tissue Antigens; 1999 May; 53(5):447-58. PubMed ID: 10372540
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunochemical and functional analysis of HLA class II antigens induced by recombinant immune interferon on normal epidermal melanocytes.
    Tsujisaki M; Igarashi M; Sakaguchi K; Eisinger M; Herlyn M; Ferrone S
    J Immunol; 1987 Feb; 138(4):1310-6. PubMed ID: 3100635
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cow's milk protein induced changes in the expression of HLA-DR antigens on colonic epithelial cells.
    Chung HL; Lee JJ; Kim SG
    Ann Allergy Asthma Immunol; 2003 Mar; 90(3):348-50. PubMed ID: 12669900
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gamma-IFN-inducible-lysosomal thiol reductase modulates acidic proteases and HLA class II antigen processing in melanoma.
    Goldstein OG; Hajiaghamohseni LM; Amria S; Sundaram K; Reddy SV; Haque A
    Cancer Immunol Immunother; 2008 Oct; 57(10):1461-70. PubMed ID: 18343923
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Allorecognition of HLA-DR and -DQ transfectants by human CD45RA and CD45R0 CD4 T cells: repertoire analysis and activation requirements.
    Merkenschlager M; Ikeda H; Wilkinson D; Beverly PC; Trowsdale J; Fisher AG; Altmann DM
    Eur J Immunol; 1991 Jan; 21(1):79-88. PubMed ID: 1671359
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression and function of class II antigens on gastric carcinoma cells and gastric epithelia: differential expression of DR, DQ, and DP antigens.
    Sakai K; Takiguchi M; Mori S; Kobori O; Morioka Y; Inoko H; Sekiguchi M; Kano K
    J Natl Cancer Inst; 1987 Nov; 79(5):923-32. PubMed ID: 2960847
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Asparagine endopeptidase is not essential for class II MHC antigen presentation but is required for processing of cathepsin L in mice.
    Maehr R; Hang HC; Mintern JD; Kim YM; Cuvillier A; Nishimura M; Yamada K; Shirahama-Noda K; Hara-Nishimura I; Ploegh HL
    J Immunol; 2005 Jun; 174(11):7066-74. PubMed ID: 15905550
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular characterization of major histocompatibility complex class II gene expression and demonstration of antigen-specific T cell response indicate a new phenotype in class II-deficient patients.
    Hauber I; Gulle H; Wolf HM; Maris M; Eggenbauer H; Eibl MM
    J Exp Med; 1995 Apr; 181(4):1411-23. PubMed ID: 7699327
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CIITA versus IFN-gamma induced MHC class II expression in head and neck cancer cells.
    Meissner M; Whiteside TL; Kaufmann R; Seliger B
    Arch Dermatol Res; 2009 Feb; 301(2):189-93. PubMed ID: 19104823
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interferon-gamma production in response to in vitro stimulation with collagen type II in rheumatoid arthritis is associated with HLA-DRB1(*)0401 and HLA-DQ8.
    Berg L; Rönnelid J; Sanjeevi CB; Lampa J; Klareskog L
    Arthritis Res; 2000; 2(1):75-84. PubMed ID: 11219392
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MHC class II-dependent activation of CD4+ T cell hybridomas by human mast cells through superantigen presentation.
    Poncet P; Arock M; David B
    J Leukoc Biol; 1999 Jul; 66(1):105-12. PubMed ID: 10410997
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IFN-gamma-stimulated enhancement of MHC class II antigen expression by the human mast cell line HMC-1.
    Love KS; Lakshmanan RR; Butterfield JH; Fox CC
    Cell Immunol; 1996 May; 170(1):85-90. PubMed ID: 8660803
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gamma-interferon causes a selective induction of the lysosomal proteases, cathepsins B and L, in macrophages.
    Lah TT; Hawley M; Rock KL; Goldberg AL
    FEBS Lett; 1995 Apr; 363(1-2):85-9. PubMed ID: 7729559
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection of aberrant association of DM with MHC class II subunits in the absence of invariant chain.
    Neumann J; König A; Koch N
    Int Immunol; 2007 Jan; 19(1):31-9. PubMed ID: 17105964
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lack of interleukin 10 regulation of antigen presentation-associated molecules expressed on colonic epithelial cells.
    Bourreille A; Segain JP; Raingeard de la Blétière D; Siavoshian S; Vallette G; Galmiche JP; Blottière HM
    Eur J Clin Invest; 1999 Jan; 29(1):48-55. PubMed ID: 10092989
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HLA-DR4 molecules in neuroendocrine epithelial cells associate to a heterogeneous repertoire of cytoplasmic and surface self peptides.
    Muntasell A; Carrascal M; Serradell L; Veelen Pv Pv; Verreck F; Koning F; Raposo G; Abián J; Jaraquemada D
    J Immunol; 2002 Nov; 169(9):5052-60. PubMed ID: 12391221
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interleukin-2 stimulates resting human T lymphocytes' response to allogeneic, gamma interferon-treated keratinocytes.
    Morhenn VB; Nickoloff BJ
    J Invest Dermatol; 1987 Nov; 89(5):464-8. PubMed ID: 3117903
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction of HLA-DR antigen on human squamous carcinoma by recombinant interferon gamma.
    Koch WM; Dugan E; Diaz LA; Richtsmeier WJ
    Laryngoscope; 1988 May; 98(5):511-5. PubMed ID: 3129628
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HLA-DM and invariant chain are expressed by thyroid follicular cells, enabling the expression of compact DR molecules.
    Catálfamo M; Serradell L; Roura-Mir C; Kolkowski E; Sospedra M; Vives-Pi M; Vargas-Nieto F; Pujol-Borrell R; Jaraquemada D
    Int Immunol; 1999 Feb; 11(2):269-77. PubMed ID: 10069425
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.